174 related articles for article (PubMed ID: 8724124)
21. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
Strouse PJ; Prince MR; Chenevert TL
Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
[TBL] [Abstract][Full Text] [Related]
22. Contrast-enhanced MR imaging of postoperative scars and VX2 carcinoma in rabbits: comparison of macromolecular contrast agent and gadopentetate dimeglumine.
Lee JW; Moon WK; Weinmann HJ; Kim SJ; Kim JH; Park SH; Kim TJ; Yoon CJ; Kim YH; Cho EY; Ha SW; Kang WS; Chang KH
Radiology; 2003 Oct; 229(1):132-9. PubMed ID: 14519873
[TBL] [Abstract][Full Text] [Related]
23. Magnetization transfer contrast in gadopentetate-dimeglumine-enhanced breast magnetic resonance imaging at 0.1 Tesla.
Dean KI; Komu M; Dean PB; Kormano M
Invest Radiol; 1994 Jun; 29 Suppl 2():S302-3. PubMed ID: 7928264
[No Abstract] [Full Text] [Related]
24. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs.
Peters JL; Shaw DD
Acta Radiol; 1993 Sep; 34(5):510-6. PubMed ID: 8369191
[TBL] [Abstract][Full Text] [Related]
26. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging contrast media in the subarachnoid space. A comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs.
Skalpe IO; Tang GJ
Invest Radiol; 1997 Mar; 32(3):140-8. PubMed ID: 9055126
[TBL] [Abstract][Full Text] [Related]
28. MR imaging of pituitary region lesions with gadodiamide injection.
Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
[TBL] [Abstract][Full Text] [Related]
29. Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs.
Bøkenes J; Hustvedt SO; Refsum H
Acad Radiol; 1997 Mar; 4(3):204-9. PubMed ID: 9084778
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of intervertebral disks with gadolinium complexes: comparison of an ionic and a nonionic medium in an animal model.
Ibrahim MA; Haughton VM; Hyde JS
AJNR Am J Neuroradiol; 1994 Nov; 15(10):1907-10. PubMed ID: 7863940
[TBL] [Abstract][Full Text] [Related]
31. Tumor imaging with a macromolecular paramagnetic contrast agent: gadopentetate dimeglumine-polylysine.
Opsahl LR; Uzgiris EE; Vera DR
Acad Radiol; 1995 Sep; 2(9):762-7. PubMed ID: 9419637
[TBL] [Abstract][Full Text] [Related]
32. [Comparative studies of the tolerability of gadodiamide, dimeglumine gadopentetate and meglumine gadoterate in MRI tests of the central nervous system].
Chanalet S; Masson B; Boyer L; Laffont J; Bruneton JN
J Radiol; 1995 Jul; 76(7):417-21. PubMed ID: 7473375
[TBL] [Abstract][Full Text] [Related]
33. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine.
Chang JM; Moon WK; Cha JH; Jung EJ; Cho N; Kim SJ
Invest Radiol; 2010 Oct; 45(10):655-61. PubMed ID: 20808238
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
Cheong BY; Duran C; Preventza OA; Muthupillai R
AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
[TBL] [Abstract][Full Text] [Related]
35. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
[TBL] [Abstract][Full Text] [Related]
36. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
37. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Madden TP; Kroeker MA
Radiology; 1992 Nov; 185(2):479-82. PubMed ID: 1410358
[TBL] [Abstract][Full Text] [Related]
38. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
Mahfouz AE; Hamm B; Taupitz M; Wolf KJ
Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging in a dog with choroid plexus carcinoma.
Ohashi F; Kotani T; Onishi T; Katamoto H; Nakata E; Fritz-Zieroth B
J Vet Med Sci; 1993 Oct; 55(5):875-6. PubMed ID: 8286551
[TBL] [Abstract][Full Text] [Related]
40. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
